S&P 500   3,329.62 (+0.39%)
DOW   29,348.10 (+0.17%)
QQQ   223.38 (+0.49%)
S&P 500   3,329.62 (+0.39%)
DOW   29,348.10 (+0.17%)
QQQ   223.38 (+0.49%)
S&P 500   3,329.62 (+0.39%)
DOW   29,348.10 (+0.17%)
QQQ   223.38 (+0.49%)
S&P 500   3,329.62 (+0.39%)
DOW   29,348.10 (+0.17%)
QQQ   223.38 (+0.49%)
Log in
In early 2019 President Trump warned this company's biggest customers to "step up their 5G efforts." A few months later, he banned their biggest competitor from doing business in the U.S. Now, this $5 stock could turn a $10,000 stake into $234,770 this year. But timing is critical. A single mention on the evening news and this opportunity could get away from you.

Kezar Life Sciences Earnings Date, Estimates & History (NASDAQ:KZR)

-0.08 (-2.39 %)
(As of 01/20/2020 04:00 PM ET)
Today's Range
Now: $3.27
50-Day Range
MA: $3.30
52-Week Range
Now: $3.27
Volume58,166 shs
Average Volume126,056 shs
Market Capitalization$62.59 million
P/E RatioN/A
Dividend YieldN/A


Kezar Life Sciences (NASDAQ:KZR) Earnings Information

Kezar Life Sciences last released its quarterly earnings data on November 6th, 2019. The reported ($0.48) earnings per share for the quarter, beating analysts' consensus estimates of ($0.51) by $0.03. Kezar Life Sciences has generated ($2.26) earnings per share over the last year. Kezar Life Sciences has not formally confirmed its next earnings publication date, but the company's estimated earnings date is Tuesday, March 24th, 2020 based off prior year's report dates.

Kezar Life Sciences Earnings Estimates and Actuals by Quarter

The chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.

Kezar Life Sciences (NASDAQ:KZR) Earnings Estimates

2020 EPS Consensus Estimate: ($2.46)
QuarterNumber of EstimatesLow EstimateHigh EstimateAverage Estimate
Q1 20201($0.59)($0.59)($0.59)
Q2 20201($0.61)($0.61)($0.61)
Q3 20201($0.62)($0.62)($0.62)
Q4 20201($0.64)($0.64)($0.64)

Kezar Life Sciences (NASDAQ KZR) Earnings History by Quarter

DateQuarterConsensus EstimateReported EPSGAAP EPSRevenue EstimateActual RevenueConference CallDetails
8/7/2019Q2 2019($0.4760)($0.46)($0.46)N/A
5/7/2019Q1 2019($0.40)($0.40)($0.40)N/A
8/9/2018Q2 2018($0.5430)($3.31)($3.31)N/A
(Earnings results data provided by Zacks Investment Research)
This page was last updated on 1/20/2020 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel